Clin Nucl Med. 2018 Jun;43(6):e170-e177. doi: 10.1097/RLU.0000000000002085.
We evaluated the feasibility of perfusion SPECT/CT for providing quantitative data for estimation of perfusion defect extent in chronic thromboembolic pulmonary hypertension (CTEPH).
Thirty patients with CTEPH underwent Tc-human serum albumin lung perfusion SPECT/CT. Perfusion defects were quantified using 3 different methods: (1) visual, semiquantitative scoring of perfusion defect extent in each lung segment, (2) threshold-based segmentation of perfused lung volumes, and (3) threshold-based segmentation of perfused lung volumes divided by segmented lung volumes at CT (perfusion index). Imaging findings were correlated with right-sided heart catheterization results and N-terminal pro-B-type natriuretic peptide. Receiver operating characteristic analysis was performed to identify SPECT thresholds for mean pulmonary arterial pressure (PAPm) greater than 50 mm Hg.
Assessment of lung perfusion provided similar results using all 3 methods. The perfusion defect score correlated with PAPm (rs = 0.60, P = 0.0005) and was associated with serum levels of N-terminal pro-B-type natriuretic peptide (rs = 0.37, P = 0.04). Perfused lung volume (40% threshold, rs = -0.48, P = 0.007) and perfusion index (40% threshold, rs = -0.50, P = 0.005) decreased as PAPm increased. Receiver operating characteristic analysis showed that perfusion defect score (sensitivity, 88%; specificity, 77%; area under the curve [AUC] = 0.89, P = 0.001), perfused lung volume (sensitivity, 88%; specificity, 64%; AUC = 0.80, P = 0.01), and perfusion index (sensitivity, 88%; specificity, 64%; AUC = 0.82, P = 0.009) could identify patients with PAPm of greater than 50 mm Hg.
Quantitative analysis of perfusion defects at SPECT is feasible, provides a measure of disease severity, and correlates with established clinical parameters. Quantitation of perfusion SPECT may refine the diagnostic approach in CTEPH providing a quantitative imaging biomarker, for example, for therapy monitoring.
我们评估了灌注 SPECT/CT 为慢性血栓栓塞性肺动脉高压(CTEPH)提供定量数据以评估灌注缺陷程度的可行性。
30 例 CTEPH 患者接受 Tc-人血清白蛋白肺灌注 SPECT/CT。使用 3 种不同方法对灌注缺陷进行定量:(1)对每个肺段的灌注缺陷程度进行视觉、半定量评分,(2)基于阈值的灌注肺容积分割,以及(3)基于阈值的灌注肺容积与 CT 分割的肺容积之比(灌注指数)。将影像学结果与右心导管检查结果和 N 末端脑利钠肽前体进行相关性分析。进行受试者工作特征分析以确定平均肺动脉压(PAPm)大于 50mmHg 的 SPECT 阈值。
使用所有 3 种方法评估肺灌注均得到相似结果。灌注缺陷评分与 PAPm 相关(rs=0.60,P=0.0005),与血清 N 末端脑利钠肽前体水平相关(rs=0.37,P=0.04)。随着 PAPm 的升高,灌注肺容积(40%阈值,rs=-0.48,P=0.007)和灌注指数(40%阈值,rs=-0.50,P=0.005)降低。受试者工作特征分析显示,灌注缺陷评分(灵敏度 88%,特异性 77%,曲线下面积[AUC]为 0.89,P=0.001)、灌注肺容积(灵敏度 88%,特异性 64%,AUC 为 0.80,P=0.01)和灌注指数(灵敏度 88%,特异性 64%,AUC 为 0.82,P=0.009)可以识别 PAPm 大于 50mmHg 的患者。
SPECT 灌注缺陷的定量分析是可行的,提供了疾病严重程度的衡量标准,并与既定的临床参数相关。灌注 SPECT 的定量分析可能会通过提供定量成像生物标志物来改进 CTEPH 的诊断方法,例如用于治疗监测。